FBR Capital Reiterates Market Perform Following Five Below (FIVE) 1Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
MKM Partners Raise Price Target on Five Below (FIVE) Following 1Q15 Results
June 4, 2015 10:39 AM EDTMKM Partners reiterates a Buy rating on Five Below (NASDAQ: FIVE), and raised the price target to $50.00 (from $41.00), following 1Q15. EPS increased 14% to $0.08 and beat MKM Partners estimate by $0.01. Same-store sales increased 1.7%.
Analyst Patrick McKeever commented, "The numbers were modest relative to trend, given a tough... More
Pre-Open Stock Movers 06/04: (BRLI) (AVEO) (FIVE) Higher; (MCP) (DRWI) (OPK) Lower (more...)
June 4, 2015 9:27 AM EDTBio-Reference Laboratories, Inc. (NASDAQ: BRLI) 42.2% HIGHER; OPKO Health (NYSE:... More
After-Hours Stock Movers 06/03: (FIVE) (FEYE) (EYES) Higher; (DRWI) (SGMO) (BLUE) Lower (more...)
June 3, 2015 5:58 PM EDTDragonWave (NASDAQ: DRWI) 17.4% LOWER; announced updated revenue expectations of approximately $27 million for its first quarter of fiscal year 2016, ended May 31, 2015. Revenue is lower than expected because shipments associated with orders received did not make the first quarter cut off. These shipments are now expected to occur in the second quarter fiscal year 2016. *** Consensus estimates call for Q1 revenue of $32 million.
Sangamo Biosciences (NASDAQ: SGMO) 7.6% LOWER; disclosed the following: On May 29, 2015, Dr. Philip D. Gregory, senior vice president, research and... More
Five Below (FIVE) Tops Q1 EPS by 1c, Comps Increase 1.7%, Offers Q2 & FY15 Guidance
June 3, 2015 4:10 PM EDTFive Below (NASDAQ: FIVE) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $153.7 million versus the consensus estimate of $151.41 million. Comparable store sales increased by 1.7%.
Five Below sees Q2 2015 EPS of $0.12-$0.13, versus the consensus... More
Trading Radar for 6/3: Vera Bradley (VRA), Verint Systems (VRNT), Five Below (FIVE), Brown Forman (BF-A) Report
June 2, 2015 2:46 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:15am EDT
8:30am EDT
Trade Balance - Street sees... More